Search

  • Français
  • Accueil
  • Programme LEA
    • Présentation
    • Gouvernance
    • Équipes impliquées
    • Partenariats
    • Nos podcasts
    • Les actualités
    • Bilan d’activité annuel
  • Hémopathies malignes
  • Principaux financeurs
  • Côté recherche
    • Publications scientifiques
    • Projets de recherche
    • Modalités d’accès aux données
    • Aspects réglementaires
  • Nous contacter
  • Accueil
  • Programme LEA
    • Présentation
    • Gouvernance
    • Équipes impliquées
    • Partenariats
    • Nos podcasts
    • Les actualités
    • Bilan d’activité annuel
  • Hémopathies malignes
  • Principaux financeurs
  • Côté recherche
    • Publications scientifiques
    • Projets de recherche
    • Modalités d’accès aux données
    • Aspects réglementaires
  • Nous contacter

Search

  • Français

Irradiation

Scientifique Publication on Iron overload in hematological malignancies

31. Lipodystrophy-like features after total body irradiation among survivors of childhood acute leukemia.

S. Visentin et al. Endocrine connections. 2019 Apr;8(4):349-359.

30. Prevalence and characteristics of metabolic syndrome in adults from the French childhood leukemia survivors’ cohort: a comparison with controls from the French population.

C. Oudin et al. Haematologica. 2018 Apr;103(4):645-654.

28. Metabolic Syndrome Among Leukemia Survivors: Still Delineating the Risk.

P. Saultier et al. Metab Syndr Relat Disord. 2017 Aug;15(6):263-265.

26. Late effects in survivors of infantile acute leukemia: a study of the L.E.A program.

V. Gandemer et al. Blood Cancer J. 2017 Jan; 7(1): e518.

25. Metabolic syndrome in long-term survivors of childhood acute leukemia treated without hematopoietic stem cell transplantation: an L.E.A. study.

P. Saultier et al. Haematologica. 2016 Dec;101(12):1603-1610.

22. Late thyroid complications in survivors of childhood acute leukemia. An L.E.A. study.

C. Oudin et al. Haematologica. 2016 Jun;101(6):747-56.

21. Educational and occupational outcomes of childhood cancer survivors 30 years afterdiagnosis: a French cohort study.

A. Dumas et al. Br J Cancer. 2016 Apr 26;114(9):1060-8.

20. Prevalence and risk factors of iron overload after hematopoietic stem cell transplantation for childhood acute leukemia: a LEA study.

A. Sirvent et al. Bone Marrow Transplant. 2016 Jan;52(1):80-87.

19. Metabolic syndrome in adults who received hematopoietic stem cell transplantation for acute childhood leukemia: an LEA study.

C. Oudin et al. Bone Marrow Transplant. 2015 Nov;50(11):1438-44.

15. Health status and quality of life of long-term survivors of childhood acute leukemia: the impact of central nervous system irradiation.

J. Benadiba et al. J Pediatr Hematol Oncol. 2015 Mar;37(2):109-16.

13. Incidence and risk factors for cataract after haematopoietic stem cell transplantation for childhood leukaemia: an LEA study.

M. Horwitz et al. Br J Haematol. 2015 Feb;168(4):518-25.

12. Health status of childhood leukemia survivors who received hematopoietic cell transplantation after BU or TBI: an LEA study.

F. Bernard et al. Bone Marrow Transplant. 2014 May;49(5):709-16.

11. Prevalence and risk factors of cataract after chemotherapy with or without central nervous system irradiation for childhood acute lymphoblastic leukaemia: an LEA study.

AL. Alloin et al. Br J Haematol. 2014 Jan;164(1):94-100.

6. Growth hormone treatment impact on growth rate and final height of patients who received HSCT with TBI or/and cranial irradiation in childhood: a report from the French Leukaemia Long-Term Follow-UpStudy (LEA).

F. Isfan et al. Bone Marrow Transplant. 2012 May;47(5):684-93.

3. Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia.

C. Oudin et al. Blood. 2011 Apr 28;117(17):4442-8.

2. Height growth during adolescence and final height after haematopoietic SCT for childhood acute leukaemia: the impact of a conditioning regimen with BU or TBI.

F. Bernard et al. Bone Marrow Transplant. 2009 Apr;43(8):637-42.
  • Nous contacter
  • Politique de confidentialité
  • Mentions légales